An estimated 20 million people have some form of age-related macular degeneration; Hadley Vision Resources aims to reach one million of them by 2030. President and CEO Johnjoe Farragher discusses help ...

Aim To compare the effect of combined low-dose transpupillary thermotherapy (TTT) and intravitreal ranibizumab with sham TTT and intravitreal ranibizumab in patients with neovascular age-related ...

Through the program, gene therapies are developed to treat patients with retinitis pigmentosa caused by pathogenic variants ...

Background Neovascular age-related macular degeneration (AMD) is a progressive and chronic disease of the eye, and a leading cause of severe blindness in elderly populations. The disease is ...

To protect your eye health and support your vision, these are 10 simple things you can do every day for your eyes.

Dry age-related macular degeneration (AMD) is the most common form of AMD and geographic atrophy (GA) is an advanced form of dry AMD, an eye disease that is a leading cause of blindness in the elderly ...

In patients with neovascular age-related macular degeneration (AMD), one of the most vision-threatening complications is submacular hemorrhage (SMH), a condition that can rapidly destroy central ...

Objectives To compare the ability of ophthalmologists versus optometrists to correctly classify retinal lesions due to neovascular age-related macular degeneration (nAMD). Design Randomised balanced ...

A new study suggests that measuring specific immune system proteins in the blood could help predict which patients with intermediate age-related macular degeneration (AMD) are most likely to ...

Source Reference: Shor R, et al "Glucagon-like peptide-1 receptor agonists and risk of neovascular age-related macular degeneration" JAMA Ophthalmol 2025; DOI: 10.1001/jamaophthalmol.2025.1455.